Free
⭐️3 / 5
Rating
🙌2
Ratings
📼5 scs
Content
📦~ in 8 months
Updates frequency
🗣❌ unsupported
Your locale
- Versions
- Price History
- Description
- FAQ
All Versions of AnticoagEvaluator
4.1
December 15, 2023
Bug fixes
4.0
September 8, 2023
This update includes underlying architecture improvements and minor reference link updates.
More3.0
January 30, 2019
This version includes the following:
1) 2019 AFib Guideline Update content
2) Design updates
More2.3
May 22, 2017
• Updated stroke risk values on no therapy in accordance with ACC/AHA Guidelines.
• Additional reference information on risk calculations.
More2.2
September 1, 2016
Updated warfarin dosing information.
2.0
December 16, 2015
•Edoxaban added to the list of available therapies
•App provides therapy selection advice from the ACC/AHA/HRC Atrial Fibrillation Guideline.
•App includes the Cockcroft-Gault creatinine clearance calculator and provides renal-function adjusted dosing for the novel oral anticoagulants
•The overall App has been updated to have a smoother look and feel based on user feedback
More1.4.1
December 13, 2014
Bug Fix
1.4
December 10, 2014
Updated for iOS8
Optimized for iPad Air, iPhone 6 and iPhone 6 Plus
1.3.59
August 15, 2014
Cosmetic changes
1.3
July 14, 2014
IOS7 ready
Price History of AnticoagEvaluator
Description of AnticoagEvaluator
Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
Show less
AnticoagEvaluator: FAQ
AnticoagEvaluator is available on iPad devices.
American College of Cardiology developed the AnticoagEvaluator app.
The minimum iOS requirement for the app is 11.0 or higher.
3.0: The AnticoagEvaluator app receives average reviews and ratings.
Medical Is The App Genre Of The Anticoagevaluator App.
4.1 is the most recent version of AnticoagEvaluator.
The latest AnticoagEvaluator update came out on July 1, 2024.
AnticoagEvaluator was first released on February 5, 2023.
AnticoagEvaluator is suitable for ages 17 and up according to its content advisory rating.
The AnticoagEvaluator app can be used in American English.
Unfortunately, AnticoagEvaluator is not on Apple Arcade.
Unfortunately, in-app purchases are not available within AnticoagEvaluator.
No, you cannot utilize AnticoagEvaluator with Apple Vision Pro.
